Jimin Health's controlling shareholder terminates transfer of 6.86% stake just two days after signing agreement

Corporate Action
โดย 财中社·Read original
Summary · why it matters

Jimin Health's controlling shareholder, Shuangge Group, has terminated the transfer of 36 million unrestricted tradable shares to Jiaxin Private Equity, representing 6.86% of the company's total share capital, for a consideration of 297 million yuan. The two parties signed the share transfer agreement on July 20, 2026, and agreed to rescind it just two days later, with all rights and obligations under the original agreement ceasing immediately. In light of the termination, Gong Guohui, head of the core management team at Great Wall Galaxy, has committed that within six months from the announcement of the asset purchase, he and core employees of Great Wall Galaxy will increase their shareholding in the company by 1% to 2% through block trades or secondary market purchases. In the first quarter of 2026, Jimin Health recorded revenue of 163 million yuan and a net loss attributable to the parent company of 25.92 million yuan.

Impact on stocks 1

Others▼ · 1 stocks
Zhejiang Chimin Pharm Co Ltd
603222
▼ NegativeCapitalrelevance

Controlling shareholder terminated a 6.86% stake transfer, signaling instability, and the company reported a net loss of 25.92 million yuan in Q1 2026.

Off-coverage companies 3

双鸽集团 (Shuangge Group)Private▼ Negative
Capitalrelevance

Shuangge Group, as controlling shareholder, terminated the share transfer agreement, indicating potential financial or strategic issues.

嘉信私募基金管理有限公司 (Jiaxin Private Fund Management)Private▼ Negative
Capitalrelevance

Jiaxin Private Equity's planned acquisition of a 6.86% stake was rescinded, losing a significant investment opportunity.

湖南长城银河科技有限公司Private▲ Positive
Capitalrelevance

Gong Guohui, head of Great Wall Galaxy's core management, committed to increasing shareholding by 1-2% within six months, signaling confidence.

© 2026 MarketDXNews